Metformin therapy and severity and mortality of SARS-CoV-2 infection: a meta-analysis
Abstract
Background:
It has been postulated that metformin could have anti-SARS-CoV-2 action. This raises the hypothesis that people who take metformin may have lower SARS-CoV-2 severity and/or mortality.
Objective
To conduct a meta-analysis of the association between the use of Metformin and risk of severity and mortality in SARS-CoV-2 infection.
Data Sources
We searched PubMed, EMBASE, Google scholar, the Cochrane Database of Systematic...
Paper Details
Title
Metformin therapy and severity and mortality of SARS-CoV-2 infection: a meta-analysis
Published Date
Sep 9, 2021
Journal
Volume
10
Issue
4
Pages
317 - 329
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History